GlassScriptPhysician profile
Sandra Alfon
NPI 1275940595
$2,725.51
in general payments reported to CMS, 2019-2025
18 companies · $709 in 2025
The $709 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $340 · 2022: $733 · 2023: $437 · 2024: $507 · 2025: $709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $348.44 | 2021-2024 | Ozempic |
| Genzyme Corporation | $272.69 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $258.91 | 2024-2025 | |
| Argenx US, INC. | $247.64 | 2024-2025 | Vyvgart |
| Abbott Laboratories | $178.78 | 2023 | Infinity |
| Gilead Sciences, INC. | $147.88 | 2025 | |
| Shield Therapeutics INC | $146.53 | 2022 | |
| Neurelis, INC. | $142.71 | 2022 | |
| Amylyx Pharmaceuticals, INC. | $133.82 | 2023 | Relyvrio |
| Teva Pharmaceuticals USA, INC. | $123.06 | 2025 | Austedo Xr |
| Silk Road Medical, INC. | $120.26 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbvie INC. | $119.32 | 2021 | |
| Dynavax Technologies Corporation | $115.84 | 2022 | |
| Tactile Systems Technology INC | $103.16 | 2025 | Flexitouch Plus, Nimbl |
| Amarin Pharma, INC. | $89.62 | 2025 | Vascepa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $81.13 | 2021 | |
| Scynexis, INC. | $80.72 | 2022 | |
| Mckesson Medical-Surgical, INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Alfon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.